Skip to main content

Enfortumab Vedotin-ejfv

Placeholder slot
 (en-FOR-too-mab veh-DOH-tin)

This page contains brief information about enfortumab vedotin-ejfv and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Enfortumab vedotin-ejfv is approved to treat adults with:

Enfortumab vedotin-ejfv is also being studied in the treatment of other types of cancer.

More About Enfortumab Vedotin-ejfv

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Enfortumab Vedotin-ejfv - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Targeted Cancer Therapies

Enfortumab Vedotin Approved for Recurrent Bladder Cancer

Monoclonal Antibodies

Clinical Trials Accepting Patients

Find Clinical Trials for Enfortumab Vedotin-ejfv - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: